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Background: As a consequence of the increasing levels of anthelmintic resistance in cyathostomes, new strategies
for equine parasite control are being implemented. To assess the potential risks of these, the occurrence of
strongyles was evaluated in a group of 1887 horses. The distribution of fecal egg counts (FECs), the frequency of
anthelmintic drug use, and the deworming intervals were also analyzed. Between June 2012 and May 2013, 1887
fecal samples from either selectively or strategically dewormed horses were collected at 195 horse farms all over
Germany and analyzed quantitatively with a modified McMaster technique. All samples with FEC ≥20 eggs per
gram (EPG) were subjected to coproculture to generate third-stage larvae (LIII) for species differentiation.
Results: Egg counts were below the limit of detection (20 EPG) in 1046 (55.4%) samples and above it in 841
(44.6%) samples. Strongylus vulgaris larvae were identified in two of the 841 positive samples. Infections with
cyathostomes were found on every farm. The most frequently applied anthelmintic was ivermectin (788/50.8%),
followed by pyrantel (336/21.6%). The mean time since last treatment was 6.3 months. High-egg-shedding (>500
EPG) strategically dewormed horses (183/1357) were treated, on average, three times/year. The planned treatment
date was already exceeded by 72.5% of the high egg-shedders and by 58.1% of the moderate (200–500 EPG) and
low egg-shedders (20–199 EPG).
Conclusions: S. vulgaris seems to be rare in Germany and no difference in its frequency has yet been found
between selectively treated horses and horses receiving treatment in strategic intervals. However, inconsistent
parasite control has been observed. Therefore, to minimize the risks for disease, consistent and efficient parasite
control should be implemented.
Keywords: Parasite control, Strongyle, S. vulgaris, Germany, Larval culture, FEC, Diagnosis, Selective anthelmintic
therapy, EquineBackground
The spread of anthelmintic resistance in cyathostome par-
asites is of growing concern to the equine industry. The
anthelmintic resistance of cyathostomes to benzimidazoles
has been reported worldwide reviewed by [1]. Cases of
pyrantel resistance in cyathostomines have also been re-
ported in studies from various countries, including England,
the United States, Italy, Brazil, Sweden, and Finland [1-8].
Several studies have also reported the reduced efficacy
of ivermectin and moxidectin against small strongyles
[9-12], and a reduction in the egg reappearance period
(ERP) after treatment with ivermectin or moxidectin* Correspondence: Miriam.Scheuerle@tropa.vetmed.uni-muenchen.de
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unless otherwise stated.[12-16]. Furthermore, it is unclear whether new classes of
drug will be developed in the near future [17].
It is now scientifically accepted internationally that the
traditional approach to parasite control with frequent
group-wise anthelmintic treatments at regular intervals
(the so-called “strategic interval treatment”) has contrib-
uted to the development of resistance [1,2,18-20]. As a
consequence and based on experience with alternative and
targeted treatment schemes in ruminants reviewed by
[21], a new strategy for equine parasite control was re-
cently introduced to delay the development of anthelmin-
tic resistance [22-25]. Selective anthelmintic therapy (SAT)
is based on the selective treatment of horses with a fecal
egg count (FEC) above a certain threshold [23,24,26,27].
Treatment thresholds of >200 eggs per gram (EPG) are
often used and are accepted internationally [24,27,28]. Theral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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preventive treatments with anthelmintics to reduce the
risk of the further development of resistance [24,28,29].
Horse owners in countries including Denmark, Sweden,
the Netherlands, and Finland have widely and successfully
used SAT for several years [23,29], and selective treatment
schemes are also used in some horse farms in South Africa
and England [22,27,30]. In Germany, the SAT method has
been introduced in some areas and has led to a reduction
in the frequency of anthelmintic treatments on these farms
[24,25,31]. SAT also contributes considerably to the main-
tenance of a parasite refugium [32].
However, it is contentious whether reducing the fre-
quency of treatments with the use of SAT will increase
the likelihood that Strongylus vulgaris will complete its
life cycle [24,28,33,34].
To assess the risks entailed in changing the anthelmin-
tic treatment schemes, we evaluated the occurrence of
strongyle infections (with an emphasis on S. vulgaris) in
groups of German horses, including selectively treated
horses and horses which were been treated in strategic
intervals. The objectives of this study were to analyze:
(a) the strongyle populations, focusing on large strongyles
(especially S. vulgaris); (b) the distributions of the FECs
and egg-shedding patterns; and (c) the application fre-
quencies of anthelmintic treatments (the last-administered




Between June 1, 2012, and May 31, 2013, 192 German
horse farms with a total of 1887 horses were included in
this study. Most horses lived in southern (909/1887,
48.2%) or western Germany (311/1887, 16.5%). The
number of horses examined on each farm ranged from 1
to 110 (mean = 9.3, median = 3). Each horse owner
signed a declaration of consent before entering the study
and agreed to follow ethical standards. The study was
conducted with strict adherence to a high standard in
veterinary care. Fecal samples were collected from the
ground. The horse owners were asked to send freshly
dropped fecal samples from their horses as part of the
routine diagnostic practice. The following data were col-
lected for each horse: age, name of the last-administered
anthelmintic drug, time of the last anthelmintic treat-
ment, mode of treatment, and the number of treatments
per year for horses receiving treatments in strategic
intervals. The horses were further divided into two sub-
groups according to the treatment strategy of the farm.
The inclusion criterion for both groups was that the
last anthelmintic treatment had been administered at
least 56 days (8 weeks) before sampling. Hence, the
specific ERPs of commonly applied anthelmintics [35]was taken into account, so potential false negative re-
sults resulting from previous treatments were excluded.
An anthelmintic drug containing moxidectin (moxidec-
tin plus praziquantel) was only administered to three of
the horses examined. Nielsen et al. [35] cited an ERP of
10–12 weeks for moxidectin. However, these three
horses had last been treated ≥37 weeks before sampling,
and hence were included in the study.
1) Horses treated according to a selective treatment
scheme
This group included 530 horses from 86 farms that
administered SAT. These farms regularly performed
FECs as an indication to deworm (FEC treatment
threshold: 200 EPG). The majority of these farms
had started using SAT 1–2 years before the study
(i.e., 345/65.1% of the selectively treated horses).
The ages of the horses in this group ranged from 2
to 39 years (mean =13.5 ± 6.37, median =13.0).2) Horses treated according to a strategic interval
treatment scheme
This group included horses that were treated
according to a strategic interval treatment scheme,
i.e., treatment at regular deworming intervals (2–6
times a year) without any previous coprological
testing. This horse group is herein after referred to
as strategic horses/strategic horse group.
In this group, 1357 horses from 106 farms were
included and the ages of the horses ranged from 1
to 36 years (mean =13.0 ± 6.90, median =13.0).
The age distributions in the selectively and strategically
treated groups did not differ significantly (p =0.138,
Man–Whitney U test; see “Statistics”).Fecal samples
One single fresh fecal sample from each horse was col-
lected from the ground by the owner. The samples were
packed in plastic boxes or bags and shipped overnight to
the parasitology laboratory, where they were kept refrig-
erated and processed within 2 days.
The fecal samples were analyzed quantitatively using a
modified McMaster technique, with a sensitivity of 20
EPG.
The levels of FECs in all 1887 horses examined were
classified according to the guidelines suggested by the
American Association of Equine Practitioners (AAEP) for
classifying horses: low (20–199 EPG), moderate (200–500
EPG), or high (>500 EPG) egg-shedders [35]. Egg-shedding
in horses with FEC <20 EPG was classified as below the
limit of detection (<20 EPG).
Larval culture
Larval culture (modified according to Roberts and
O’Sullivan [36]) was performed for all 841 (44.6%) fecal
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feces were weighed, put into plastic boxes, and incubated
for 2 weeks at room temperature. During this time, the
samples were regularly checked for desiccation, moistened
if necessary, and ventilated for 1 hour every day. After in-
cubation, the infectious larvae (L3) were harvested after
sedimentation for at least 12 hour at 10°C (in a beaker).
An aliquot of 100 μl was obtained from the sediment
(1000 μl) containing the accumulated larvae. All the third-
stage larvae (L3) of small and large strongyles, second-stage
larvae (L2), and free-living rhabditiform nematodes were
identified and counted. The remaining sediment (900 μl)
was then analyzed for large strongyles. The strongyles were
taxonomically identified according to Bürger and Stoye
[37]. All cultures were examined by the same person.
Statistics
The data were analyzed using IBM® SPSS® Statistics 21
(IBM Corporation, Armonk, USA) and Microsoft Excel
2010 (Microsoft Corporation, Seattle, USA). The distribu-
tions of the FEC results were compared between the two
groups of differently treated horses using the Mann–
Whitney U test. An independent-samples t test was used
to compare the mean number of months between the last
deworming and sampling for the two treatment groups.
All statistical tests were deemed to be significant at
p <0.05. The high-egg-shedding horses (FEC >500 EPG) of
the strategically treated group were also investigated for
deworming frequency, i.e., number of treatments per year,
the last treatment occasion, and the next planned treat-
ment date. Therefore, the “planned days between treat-
ments per year” was estimated for each horse by dividing
365 days by the factor “treatments per year”, and this was
added to the reported date of the last treatment to calcu-
late the “planned next treatment date”. Seasonal influences
were not considered in this calculation.
Results
Larval cultures
S. vulgaris was detected in the larval cultures from 2/841
strongyle-positive samples, i.e., a single sample from each
treatment group. Only one S. vulgaris larva was identified
in each treatment groups.
Cyathostomine larvae were found in at least one sample
on every farm (both subgroups), making the prevalence
100% at the farm level. The mean number of cyathosto-
mine larvae per aliquot (100 μl =1 g of feces) was 292
(median, 101); the maximal number per aliquot was 5872.
No small strongyles at all were found in four of 841 larval
coprocultures.
FECs
Altogether, 1887 fecal samples were analyzed, and in
1046 (55.4%), FECs were below the level of detection.The distribution of FECs in all 1887 horses examined,
separated into the strategic (1a) and selective groups
(1b), is shown in Figure 1.
The FECs of the selectively treated group were distrib-
uted as follows: maximum = 4040 EPG, mean = 202 EPG,
and median = 20 EPG. The FEC distribution for the stra-
tegically treated horses was: maximum = 8200 EPG, mean
= 203 EPG, and median = 0 EPG. There was no statisti-
cally significant difference in the distributions of the FECs
of the two treatment groups (Mann–Whitney U test). Ac-
cording to this classification, a low level of egg-shedding
was found in 18.8% (255) and 33.8% (173) of horses in the
strategically and selectively treated group, respectively,
whereas 7.9% (107) of strategically treated horses and
11.9% (63) of selectively treated horses showed moderate
levels of egg-shedding. More horses in the strategic group
(13.5%, 183/1357) showed a high level of egg-shedding
than in the selective group (10.2%, 54/530) (Figure 1a).
The added percentage of horses “below the detection
limit” and with “low egg-shedding” of the two treatment
groups is comparable (78%).
Deworming interval
The data for 81.5% (1538/1887) of the horses were avail-
able for this analysis: 393 selectively treated horses and
1145 strategically treated horses. For all horses, the
mean time between the last treatment and sampling was
6.3 months: selective group, 8.6 months; strategic group,
5.5 months. The difference in the mean number of
months between the two groups was statistically signifi-
cant (p = 0.000). The majority of strategically treated
horses were dewormed less than 24 weeks before examin-
ation: 10.2% (117/1145) between 8–12 weeks and 57.9%
(663/1145) between 13–24 weeks (Figure 2). In the stra-
tegic group, 27.3% (313/1145) of horses were dewormed
25–36 weeks before examination. In contrast, the horses
in the selective group were dewormed less frequently.
More than 50% of them were dewormed >24 weeks before
sampling, 15.3% (60/393) 25–36 weeks before sampling,
33.8% (133/393) 37–48 weeks before sampling, and 12.5%
(49/393) >48 weeks before sampling. Only 4.5% (52/1145)
of strategically treated horses were dewormed >36 weeks
before sampling: 49 horses 37–48 weeks before sampling
and three horses >48 weeks before sampling (Figure 2).
Last anthelmintic drug used
Data for 82.2% (1552/1887) of the horses were available
for this analysis: 431 selectively treated horses and 1121
strategically treated horses. The distribution (%) of the
last-administered anthelmintic drugs among the partici-
pating horses (numbers in boxes) is shown in Figure 3.
Horse owners most frequently administered ivermectin
(selective group, 65.7% [284/431]; strategic group, 45.0%
[504/1121]). Pyrantel was administered to 16.7% (72/
Figure 1 Distributions of the egg-shedding levels. Comparison of the selectively (a) and strategically (b) treated horse groups (numbers in
each group and percentages).
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1121) of the strategically treated horses. The combination
of ivermectin/praziquantel was used in 14.1% (61/431) of
the selectively treated horses and 22.7% (254/1121) of the
strategically treated horses. Three horses treated with the
combination moxidectin/praziquantel (one selectively and
two strategically treated horses) are not included in this
figure.
Distribution of FECs after deworming
The distribution of FECs and the days between deworm-
ing with ivermectin (IVM, a), pyrantel (PYR, b), fenben-
dazole (FEN, c), or ivermectin/praziquantel (IVM/PRAZ,Figure 2 Time (weeks) since the last anthelmintic treatment. Comparis
(numbers in each group and percentages).d) and sampling are presented in Figure 4. The corre-
sponding ERPs, depending on which anthelmintic drug
was used, are marked with red lines, and the mean FECs
within the respective time frames (segment lengths:
100 days each) are marked with orange lines. The starting
point for sampling was 56 days after the last deworming
and is marked with a blue line.
Immediately after ERP, low-, moderate-, and high-egg-
shedding horses were found in all four treatment groups
(Figure 4). This was also true of horses that were
dewormed >100 days before sampling. Zero EPGs were
detected up to 746 days after treatment. Neither the in-
dividual FECs nor the mean FECs within the respectiveon of the selectively (a) and strategically (b) treated horse groups
Figure 3 Distributions (%) of the last-administered anthelmintic drugs among the horses (numbers in boxes). Comparison of the
selectively (red) and strategically (blue) treated horse groups. (FBZ, fenbendazole; IVM, ivermectin; PRAZ, praziquantel; MOX, moxidectin;
PYR, pyrantel).
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since the last treatment, regardless of the drug used
(Figure 4).
Deworming frequency and actual planned next treatment
date
The deworming frequencies and the last and next planned
treatment dates were examined in the high egg-shedders
(183/1357, 13.5% of horses) in the strategic group. On
average, three treatments per year (range: 2–6/year)
were planned. The majority of horse owners planned
two (78/183, 42.6%) or four (62/183, 33.8%) treatments
per year. Three and six anthelmintic treatments were
planned for 15.9% (29/183) and 1.1% (2/183) of strategic-
ally treated horses, respectively. No data for deworming
frequency were received for 6.6% (12/183) of the stra-
tegically treated high-egg-shedding horses. When the
estimated planned next treatment date was compared
with the sampling date, 72.5% (124/171) of the strategic-
ally treated high egg-shedders had already exceeded their
planned next treatment date, on average by 46 days.
The same estimations of the strategically treated mod-
erate and low egg-shedders showed that 58.1% (187/322)
of the horses (40 horses lacked the relevant data) were
scheduled to be treated, on average, 40 days before the
respective sampling date.
Discussion
The spread of SAT and the first experiences of its imple-
mentation in the field have prompted discussion of the
risks this treatment scheme might entail [29]. One majorpoint of debate is the possible reemergence of S. vulgaris,
potentially caused by a reduction in the frequency of an-
thelmintic treatments when SAT is administered [28,38,39].
Other potential problems in parasite control are the risk of
the inappropriate implementation of the parasitic treatment
scheme [39] and the failure to reliably identify high-egg-
shedding horses, which are a higher contamination risk
for other horses (because of the phenomenon of “egg-
shedding consistency”) [24,26,32,40,41].
The risk of infection with S. vulgaris in Germany seems
very low at the moment, because the low detection fre-
quency of S. vulgaris presented here (2/841 S. vulgaris-
positive samples) is consistent with results of several other
studies in southern Germany, Brandenburg, and north
Rhine-Westphalia [31,42-44]. Therefore, the situation in
Germany seems to be very favorable for the implementa-
tion of SAT. In several neighboring countries, including
Denmark, Poland, Italy, Switzerland, and the Netherlands,
the prevalence of S. vulgaris is higher than that observed
in Germany [38,40,45-49]. However, it must be kept in
mind that the diagnostic and evaluation methods used in
all these studies differed, which makes it difficult to inter-
pret and compare the data. In the present study, individual
fecal samples and the complete sedimented larvae from
each horse were analyzed. In contrast, many protocols in
other studies used pooled fecal samples [40,43,44,48,49],
only identified the first 100 larvae [40,43,44,48], or only
analyzed an aliquot of each sample [31]. The higher
numbers of S. vulgaris stages reported in Poland and
Italy can be attributed to the performance of postmor-
tem analyses [45-47]. However, the Danish results [38]
Figure 4 Distributions of fecal egg counts (FECs) after treatment. (a) With ivermectin (IVM); (b) pyrantel (PYR); (c) fenbedazole (FEN); and (d)
ivermectin/praziquantel (PRAZ).
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to the comparatively high prevalence of S. vulgaris in
Denmark in the past [50] and the long treatment inter-
vals common there now [38] because a law introduced
in 1999 requires that anthelmintic drugs be obtained on
prescription [19]. Nielsen et al. [38] showed a mean
time since the last deworming of 9.6 months, which is
more than three months longer than that in the present
study. This shows that SAT regimes may differ consider-
ably, and the impact that these variations in the imple-
mentation of SAT will have in the long-term is unclear.
The missing or irregular examination of larval cultures
reportedly practiced by Danish veterinarians [28] might
be another reason for the higher prevalence of S. vulgaris
in that country. However, the prevalence of S. vulgaris
must be monitored continuously, especially when trying
to reduce the frequency of treatments [29]. There is a defin-
ite risk that S. vulgaris will spread in response to the higher
S. vulgaris prevalence in neighboring countries. The strictimplementation of SAT includes regular monitoring
with FECs and larval cultures to analyze the FEC pat-
terns and to limit the reemergence of large strongyles
within a herd [29,33].
As expected, the ubiquitous occurrence of cyathostomes
demonstrated by various German and international stud-
ies is supported by the findings of the present study
[23,25,27,43,44,51-55]. Cyathostome larvae were found in
at least one sample from every farm. This will not neces-
sarily cause major problems, but heavy infections with
cyathostomes must be prevented to avoid clinical larval
cyathostominosis [56-58]. Therefore, treatment programs
must be based on the control of cyathostomes.
The use of SAT (leaving animals untreated for some
time) is made possible by the fact that the majority of
horses are low egg-shedders [33,40,49,59,60], as ob-
served in the present study. It is interesting to note that
the added percentage of horses “below detection” and
with “low egg-shedding” were almost equal (~78%) in
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with lower treatment frequencies in the selective group,
supports the idea of SAT, providing that FEC <200 EPG
are thought to be acceptable. The reported consistency of
egg-shedding by individual horses over time [24,30,32,40]
is an additional safety factor when the intervals between
treatments or sampling are increased in stable groups of
horses. However, the optimal intervals between fecal sam-
pling must be determined individually [24,29]. Although
long treatment intervals do not seem to affect most horses
clinically, they may enable parasitic species with long life
cycles, such as S. vulgaris, to spread and might lead to in-
creasing infection pressure on the pasture [24,28,33,34].
Recent publications recommend at least one “safety”
treatment for all horses in a herd once a year, together
with strict quarantine measures for newly arrived
horses [29,33,35].
Prolonged examination intervals in selectively treated
horses, as well as undetected high egg-shedders, overdue
treatments, and inappropriate treatment frequencies in
strategically treated horses (as seen in the present study)
may increase the risk of parasitic disease. More than half
the high-egg-shedding strategically treated horses in this
study were treated two or three times a year, which is in-
sufficient to effectively reduce their egg-shedding rates.
The insufficient involvement of veterinarians in parasite
management programs might also explain the overdue
treatments in the strategic horse group. Nevertheless, it
has to be mentioned, that horse owners with good com-
pliance and a chosen strategic treatment interval of
61 days (6 treatments/year), might easily be excluded
due to the study design (no treatment with 56 days prior
to sampling). However, recent German and international
studies show that the majority of German horses are
treated 2 to 4 times a year [39,61]. Therefore, we assume
that a possible bias should be negligible. A positive side
effect of SAT is that veterinarians will regain influence
in parasite management programs, and regular examina-
tions at the herd level will be practiced [19,28,33].
In this study, the selectively treated group showed
lower FECs and contained fewer high egg-shedders than
the strategically treated group. The risk of undetected
high egg-shedders should also be lower in selectively
treated horses than in strategically treated horses, if
regular fecal sampling is reliably performed and if all
horses that exceed the predetermined egg count thresh-
old are dewormed [24,33,38].
As well as regular coproscopic diagnosis, the use of
suitable, effective anthelmintics at adapted treatment in-
tervals is important. As in other studies, ivermectin was
the most widely used drug in this study [18,39,62,63].
Knowledge of the widespread benzimidazole resistance
in cyathostomes reviewed by [1] and the efficacy of
macrocyclic lactones (ivermectin and moxidectin) [4]might be responsible for this preference of ivermectin.
However, the efficacy of any drug used must be verified
at regular intervals [33,64,65].
In this study, only horses sampled after the respective
ERP [35] were included, to eliminate false-negative FEC
results caused by recent treatment. The FECs of all egg-
shedding levels were observed immediately after ERP, re-
gardless of the class of drug used. This supports the hy-
pothesis of egg-shedding consistency, because the level
of egg-shedding seems to be independent of the time since
the last deworming, but is instead dependent on the status
of the individual horse [24,30,32,40].
Every parasite control program should be based on
continuous and consequent helminthological monitoring
[20,33,66,67], the sensible use of anthelmintic drugs, in-
cluding a “safety” treatment, or a few defined strategic
interval treatments per year [29,33,68]. The efficacy of the
anthelmintic drugs should also be monitored to detect
resistance [2,33,64,65,68]. The AAEP recently presented
guidelines for parasite control [35]. The introduction of
similar practical guidelines for SAT and other new strat-
egies could help veterinarians with the future implementa-
tion of effective parasite control.Conclusions
The majority of all horses examined were defined as low
strongyle egg-shedders or below the limit of detection.
Despite the long treatment intervals in some horses, no in-
crease in FEC levels was found. However, some high egg-
shedders remain undetected and without treatment for too
long, especially in strategically treated groups. Our results
also indicate that the risk of infections with large strongyles
(S. vulgaris) in Germany is relatively small at the moment.
To date, no effect of these two treatment strategies on the
frequency of S. vulgaris has been determined. Thus, the
implementation of SAT in Germany seems to be feasible
at the moment. Nevertheless, a strict, regular, and consist-
ent parasite management program, independent of the
treatment strategy, is necessary for adequate and low-
risk parasite control. Therefore, an internationally ac-
cepted guideline is urgently required to keep this risk
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